Fluoxetine for Depression, Anxiety, and Related Conditions: An Overview of Clinical Uses

Fluoxetine is a selective serotonin reuptake inhibitor, or SSRI, and was the first member of this class to receive FDA approval in the United States in 1987. It remains among the most widely prescribed antidepressants in the world and is available under the brand name Prozac as well as numerous generic formulations. Its long half-life, broad indication profile, and well-established safety data make it a foundational agent in psychiatric and primary care prescribing. The primary mechanism of fluoxetine involves blocking the serotonin transporter protein, which reduces the reuptake of serotonin from the synaptic cleft back into the presynaptic neuron. The resulting increase in synaptic serotonin availability modulates neural circuits involved in mood regulation, anxiety, and behavioral control. FDA-approved indications for fluoxetine include major depressive disorder in adults and pediatric patients, obsessive-compulsive disorder, bulimia nervosa, panic disorder, and bipolar depression in combination with olanzapine. Off-label uses that have evidence support include premenstrual dysphoric disorder, generalized anxiety disorder, post-traumatic stress disorder, and social anxiety disorder. The pediatric approval for fluoxetine in major depressive disorder and OCD distinguishes it from most other SSRIs with pediatric clinical trial data that supported this labeling. Prescribers working with younger patients often consider fluoxetine specifically because of this evidence base. Fluoxetine's exceptionally long half-life, approximately two to three days for the parent drug and up to one to two weeks for its active metabolite norfluoxetine, is a key clinical feature. This prolonged action reduces the severity of discontinuation symptoms if doses are missed and allows more flexibility in dosing schedules. Some patients are switched to fluoxetine specifically to facilitate a more gradual tapering process when stopping antidepressant therapy. Common tolerability considerations include insomnia, nausea, headache, sexual side effects, and mild activation or agitation particularly during initiation. These effects are typically manageable and often improve over the first few weeks. For patients beginning fluoxetine or wanting to understand its clinical profile better, learning about fluoxetine for depression and anxiety management provides a comprehensive overview. For patients comparing SSRIs and other antidepressant classes, the resources at antidepressant medication category guides offer valuable context for treatment discussions.